1. Home
  2. KVYO vs BAX Comparison

KVYO vs BAX Comparison

Compare KVYO & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Klaviyo Inc. Series A

KVYO

Klaviyo Inc. Series A

HOLD

Current Price

$28.54

Market Cap

8.8B

Sector

N/A

ML Signal

HOLD

Logo Baxter International Inc.

BAX

Baxter International Inc.

HOLD

Current Price

$21.04

Market Cap

10.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KVYO
BAX
Founded
2012
1931
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.8B
10.2B
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
KVYO
BAX
Price
$28.54
$21.04
Analyst Decision
Strong Buy
Hold
Analyst Count
23
10
Target Price
$42.83
$25.00
AVG Volume (30 Days)
3.0M
8.4M
Earning Date
02-18-2026
02-12-2026
Dividend Yield
N/A
0.19%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,153,988,000.00
$11,023,000,000.00
Revenue This Year
$32.38
$5.20
Revenue Next Year
$21.60
$2.00
P/E Ratio
N/A
N/A
Revenue Growth
32.81
3.90
52 Week Low
$23.44
$17.40
52 Week High
$49.55
$37.74

Technical Indicators

Market Signals
Indicator
KVYO
BAX
Relative Strength Index (RSI) 41.90 69.89
Support Level $27.87 $20.08
Resistance Level $30.06 $19.49
Average True Range (ATR) 1.35 0.46
MACD -0.52 0.21
Stochastic Oscillator 21.16 90.00

Price Performance

Historical Comparison
KVYO
BAX

About KVYO Klaviyo Inc. Series A

Klaviyo Inc is a technology company that provides a software-as-a-service (SaaS) platform to enable its customers to send the right messages at the right time across email, short message service, and push notifications, more accurately measure and predict performance, and deploy specific actions and campaigns. The platform combines proprietary data and application layers into one solution with machine learning and artificial intelligence capabilities. It is focused on marketing automation within eCommerce as its first application use case. It generates revenue through the sale of subscriptions to its customers for the use of its platform. Geographically, the company generates the majority of its revenue from the Americas, followed by EMEA and APAC.

About BAX Baxter International Inc.

Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.

Share on Social Networks: